Getting a molecule to IND enabling studies and first-in-human testing represents a major milestone for most companies. And for VC backed companies, it can represent a major financial milestone - enabling future development activities. AustinPx understands the importance of the preclinical development phase, and provides key services to support the transition from discovery to clinical development, including:
- Molecule Characterization
- Preformulation Testing
- Formulations for Toxicology Studies
- Formulation Technology Screening